Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

THE OCCURRENCE OF SPECIFIC IMMUNITY PRINCIPLES IN THE BLOOD OF VACCINATED CALVES.

The Journal of experimental medicine·2009
Same author

SERUM TREATMENT OF EPIDEMIC CEREBRO-SPINAL MENINGITIS.

The Journal of experimental medicine·2009
Same author

AN ANALYSIS OF FOUR HUNDRED CASES OF EPIDEMIC MENINGITIS TREATED WITH THE ANTI-MENINGITIS SERUM.

The Journal of experimental medicine·2009
Same author

STUDIES IN FERMENT ACTION : II. THE EXTENT OF LEUCOCYTIC PROTEOLYSIS.

The Journal of experimental medicine·2009
Same author

STUDIES ON FERMENT ACTION : III. A SPECIFIC IMMUNE LIPASE.

The Journal of experimental medicine·2009
Same author

STUDIES ON FERMENT ACTION : V. IMMUNIZATION WITH PROTEOLYTIC CLEAVAGE PRODUCTS OF PNEUMOCOCCI.

The Journal of experimental medicine·2009

Related Experiment Video

Updated: Jun 19, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

STANDARDIZATION OF THE ANTIMENINGITIS SERUM.

J W Jobling1

  • 1Laboratories of the Rockefeller Institute for Medical Research, New York.

The Journal of Experimental Medicine
|October 30, 2009
PubMed
Summary
This summary is machine-generated.

Standardizing antimeningitis serum is challenging due to variable bacterial infectivity and animal responses. Measuring specific opsonins offers a viable method for standardizing serum therapeutic activity.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Area of Science:

  • Immunology
  • Microbiology
  • Medical Diagnostics

Background:

  • Standardizing antimeningitis serum is difficult due to Diplococcus intracellularis variability.
  • Virulence and endotoxic value are unreliable metrics for serum standardization.
  • Complement-binding power lacks a clear correlation with therapeutic efficacy.

Purpose of the Study:

  • To identify a reliable method for standardizing antimeningitis serum.
  • To explore the potential of specific opsonins as a standardization metric.
  • To propose a practical approach for serum standardization.

Main Methods:

  • Evaluating Diplococcus intracellularis infectivity and animal responses.
  • Assessing complement-binding power of antimeningitis serum.
  • Investigating the role of specific opsonins in infection recovery.
  • Quantitatively estimating opsonic content in antimeningitis serum.

Main Results:

  • Diplococcus intracellularis infectivity and endotoxin reactions are too variable for standardization.
  • Complement-binding assays are not suitable for standardizing therapeutic activity.
  • Specific opsonins play a key role in recovery from Diplococcus intracellularis infections.
  • Quantitative opsonic estimation provides a viable standardization method.

Conclusions:

  • Opsonic content is a reliable measure for standardizing antimeningitis serum.
  • A minimum dilution activity of 1:5,000 in opsonins is proposed as a standard.
  • This method is practical and applicable for commercial antimeningitis serum, given opsonin stability.